Literature DB >> 17635928

Regulator of G Signaling 16 is a marker for the distinct endoplasmic reticulum stress state associated with aggregated mutant alpha1-antitrypsin Z in the classical form of alpha1-antitrypsin deficiency.

Tunda Hidvegi1, Karoly Mirnics, Pamela Hale, Michael Ewing, Caroline Beckett, David H Perlmutter.   

Abstract

In the classical form of alpha(1)-antitrypsin deficiency, a mutant protein accumulates in a polymerized form in the endoplasmic reticulum (ER) of liver cells causing liver damage and carcinogenesis by a gain-of-toxic function mechanism. Recent studies have indicated that the accumulation of mutant alpha(1)-antitrypsin Z in the ER specifically activates the autophagic response but not the unfolded protein response and that autophagy plays a critical role in disposal of insoluble alpha(1)-antitrypsin Z. In this study, we used genomic analysis of the liver in a novel transgenic mouse model with inducible expression to screen for changes in gene expression that would potentially define how the liver responds to accumulation of this mutant protein. There was no unfolded protein response. Of several distinct gene expression profiles, marked up-regulation of regulator of G signaling (RGS16) was particularly notable. RGS16 did not increase when model systems were exposed to classical inducers of ER stress, including tunicamycin and calcium ionophore, or when a nonpolymerogenic alpha(1)-antitrypsin mutant accumulated in the ER. RGS16 was up-regulated in livers from patients with alpha(1)-antitrypsin deficiency, and the degree of up-regulation correlated with the hepatic levels of insoluble alpha(1)-antitrypsin Z protein. Taken together, these results indicate that expression of RGS16 is an excellent marker for the distinct form of "ER stress" that occurs in alpha(1)-antitrypsin deficiency, presumably determined by the aggregation-prone properties of the mutant protein that characterizes the deficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635928     DOI: 10.1074/jbc.M704330200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.

Authors:  Nicholas Maurice; David H Perlmutter
Journal:  Clin Transl Sci       Date:  2012-01-10       Impact factor: 4.689

Review 2.  Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth.

Authors:  Ming Liu; Israel Hodish; Leena Haataja; Roberto Lara-Lemus; Gautam Rajpal; Jordan Wright; Peter Arvan
Journal:  Trends Endocrinol Metab       Date:  2010-08-18       Impact factor: 12.015

3.  Mechanisms underlying the cellular clearance of antitrypsin Z: lessons from yeast expression systems.

Authors:  Cristy L Gelling; Jeffrey L Brodsky
Journal:  Proc Am Thorac Soc       Date:  2010-11

4.  NFκB mitigates the pathological effects of misfolded α1-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms.

Authors:  Amitava Mukherjee; Tunda Hidvegi; Patrick Araya; Michael Ewing; Donna B Stolz; David H Perlmutter
Journal:  Cell Death Differ       Date:  2018-05-23       Impact factor: 15.828

5.  Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-10-06

Review 6.  Advances in alpha-1-antitrypsin deficiency liver disease.

Authors:  Jeffrey H Teckman; Ajay Jain
Journal:  Curr Gastroenterol Rep       Date:  2014-01

Review 7.  Pleiotropic functions of EAPII/TTRAP/TDP2: cancer development, chemoresistance and beyond.

Authors:  Chunyang Li; Shi-Yong Sun; Fadlo R Khuri; Runzhao Li
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

8.  Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency.

Authors:  Nancy Y Marcus; Elizabeth M Brunt; Keith Blomenkamp; Faiza Ali; David A Rudnick; Muneeb Ahmad; Jeffrey H Teckman
Journal:  Hepatol Res       Date:  2010-06       Impact factor: 4.288

Review 9.  Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.

Authors:  David H Perlmutter; Gary A Silverman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 10.  Functions of autophagy in normal and diseased liver.

Authors:  Mark J Czaja; Wen-Xing Ding; Terrence M Donohue; Scott L Friedman; Jae-Sung Kim; Masaaki Komatsu; John J Lemasters; Antoinette Lemoine; Jiandie D Lin; Jing-hsiung James Ou; David H Perlmutter; Glenn Randall; Ratna B Ray; Allan Tsung; Xiao-Ming Yin
Journal:  Autophagy       Date:  2013-05-22       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.